The expression of SLC2A5 is reported to be regulated by many factors such as substrate level, tumor hypoxia, oncogene, inflammatory factor TNF-α, and hormone levels (insulin, thyroxine, etc.)in other tumors, but its modulation in lung cancer remain unknown. The gene discussed is INS; the disease is lung cancer.